Literature DB >> 22164771

Vitexin inhibits polyubiquitin synthesis by the ubiquitin-conjugating enzyme E2-25K.

Kimberli M Helms1, Randall C Wilson, Ifedayo V Ogungbe, William N Setzer, Pamela D Twigg.   

Abstract

An extract of bark from the tropical rainforest plant Byrsonima crassifolia was screened for inhibition of diubiquitin formation by the human ubiquitin-conjugating enzyme E2-25K. Activity assays with both the full-length enzyme and a truncated, active catalytic UBC domain revealed that the extract contained inhibitory properties. Separation of the extract into individual components and additional screens identified vitexin as the active inhibitor. An IC50 for vitexin was calculated to be approximately 0.5 mM. Molecular modeling simulations were used to predict the mode of inhibition and NMR spectra were used to confirm the binding site of vitexin to E2-25K.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22164771

Source DB:  PubMed          Journal:  Nat Prod Commun        ISSN: 1555-9475            Impact factor:   0.986


  1 in total

1.  In Vitro Testing of Crude Natural Plant Extracts from Costa Rica for Their Ability to Boost Innate Immune Cells against Staphylococcus aureus.

Authors:  Ragheda Yaseen; Katja Branitzki-Heinemann; Hani Moubasher; William N Setzer; Hassan Y Naim; Maren von Köckritz-Blickwede
Journal:  Biomedicines       Date:  2017-07-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.